Estimated Long-Term Benefits of Finerenone in Heart Failure
JAMA Cardiology
SEPTEMBER 26, 2024
This prespecified analysis of the Finerenone Trial to Investigate the Efficacy and Safety Superior to Placebo in Patients With Heart Failure (FINEARTS-HF) randomized clinical trial investigates the long-term effects of treatment with the nonsteroidal mineralocorticoid receptor antagonist, finerenone, in patients with heart failure with mildly reduced or preserved ejection fraction.
Let's personalize your content